Monday, March 12, 2018

Future Of The Moroccan Defense Industry- Ken Research


The Future of the Moroccan Defense Industry-Market Attractiveness, Competitive Landscape and Forecasts to 2022, published by Strategic Defence Intelligence, provides readers with detailed analysis of both historic and forecast defense industry values, factors influencing demand, the challenges faced by industry participants, analysis of industry leading companies, and key news. Morocco's defense expenditure decreased from US$3.8 billion in 2013 to US$3.4 billion in 2017, at a CAGR of -2.80%. 
The decline in defense spending is primarily attributed to the drop-in exchange rates of Moroccan Dirham's (MAD) with respect to US dollars. The country consistently imports advanced arms and ammunitions such as fighter and training aircraft, ships, missiles, tanks, and frigates to strengthen its armed forces; a trend expected to continue over the forecast period. The defense budget is expected to increase from US$3.5 billion in 2018 to US$3.9 billion by 2022, reflecting a CAGR of 2.80%. Morocco's future procurement plan includes warplanes, helicopters, submarines, radar systems, and naval vessels. On a cumulative basis, the country is expected to invest US$18.6 billion for defense purposes, of which US$5.7 billion is earmarked for capital expenditure to fund defense procurements. The government's well-defined military modernization plans to counter influence of Algeria are expected to corner significant part of investment. The MoD is expected to invest in fighters & Diesel Electric Submarine, Military-IT & Networking and Anti-Tank Missiles over the coming years. This report offers detailed analysis of the Moroccan defense industry with market size forecasts covering the next five years. This report will also analyze factors that influence demand for the industry, key market trends, and challenges faced by industry participants. In particular, it provides an in-depth analysis of the following:
The Moroccan defense industry market size and drivers: detailed analysis of the Moroccan defense industry during 2018-2022, including highlights of the demand drivers and growth stimulators for the industry. It also provides a snapshot of the country's expenditure and modernization patterns.
Budget allocation and key challenges: insights into procurement schedules formulated within the country and a breakdown of the defense budget. It also details the key challenges faced by defense market participants within the country.
Porter's Five Force analysis of the Moroccan defense industry: analysis of the market characteristics by determining the bargaining power of suppliers, bargaining power of buyers, threat of substitution, intensity of rivalry, and barriers to entry.
Import and Export Dynamics: analysis of prevalent trends in the country's imports and exports over the last five years.
Market opportunities: details of the top five defense investment opportunities over the next 10 years.
Competitive landscape and strategic insights: analysis of the competitive landscape of the Moroccan defense industry. It provides an overview of key players, together with insights such as key alliances, strategic initiatives, and a brief financial analysis. This report will give the user confidence to make the correct business decisions based on a detailed analysis of the Moroccan defense industry market trends for the coming five years. The market opportunity section will inform the user about the various military requirements that are expected to generate revenues during the forecast period. The description includes technical specifications, recent orders, and the expected investment pattern by the country during the forecast period. Detailed profiles of the top domestic and foreign defense manufacturers with information about their products, alliances, recent contract wins and financial analysis wherever available. This will provide the user with a total competitive landscape of the sector. A deep qualitative analysis of the Moroccan defense industry covering sections including demand drivers, Porter's Five Forces Analysis, Key Trends and Growth Stimulators, and latest industry contracts.
Key Topics Covered in the Report:-
Moroccan Defense Industry Research Report
Moroccan Defense Industry Revenue
Moroccan Defense Industry Forecast
Moroccan Defense Market Size
Moroccan Defense Industry Future Outlook
Moroccan Defense Industry Value
Moroccan Defense Market Growth Analysis
Moroccan Defense Industry Shares
Moroccan Defense Industry Trends
Moroccan Defense Industry Competition
Moroccan Defense Industry Opportunities
Moroccan Defense Market Analysis
Future Of The Moroccan Defense Industry

To know more, click on the link below:-


Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
0124-4230204

Animal Specialty Drugs to Boost Global Animal Medicine Market in the Future: Ken Research


The report titled “Animal Medicine Global Market Report 2018”, provides a comprehensive analysis of global animal medicine market, stem cell therapy, animal specialty drugs, animal specialty drugs leading players, investments in R&D, factors affecting the growth of animal drugs, animal health products, and future of global animal medicine.
Industry Overview: Global veterinary market offers huge opportunities for growth in pharmaceutical, medical and service companies due to the global increase in pet numbers and expenditure. Majority of the animal medicines available globally are used at veterinary clinics to control and treat animal diseases. Global veterinary pharmaceutical companies produce both generic and branded animal drugs for various treatments. Almost all the veterinary pharmaceutical producers are using Stem Cell Therapy as an animal medicine because it has excellent capabilities of healing arthritis and animal injury. The process of injecting stem cell into the body of the animal to replace the damaged cells is termed as stem cell therapy and the injected stem cells acquires the property of the cell that has to be replaced. These cells divide themselves into many cells as required by the animal body. This therapy is used to treat bone injury, ligament injury, kidney diseases, liver disease and various kinds of skin diseases.
Animal Specialty Drugs: Animal specialty drugs are more prominent now-a-days such as vaccines, antibiotics, parasiticides, feed additives, and others. They are available at veterinary hospitals, pet care clinics, and pharmacy stores across all regions globally. The leading players in the global animal specialty drugs market are Bayer, Elanco, Merial, and Zoetis. Preventive healthcare in animals also includes periodic examination of animals, dental care, prophylaxis for various infections, and risk factor assessment, nutrition, and vaccinations. Globally pet lovers are aware about the need for disease prevention and better animal specialty drugs for medications, treatment, and care for pets or animals.
Veterinary drugs manufacturers are focusing on the development of novel drugs for animals by investing heavily in R&D activities. Toxoid vaccines, attenuated live vaccines, inactivated vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines are the various types of animal medicines or vaccines. Veterinary hospitals provide a range of healthcare services such as diagnosis, prophylaxis, medical treatment, and surgery to the animals. The animal specialty drugs market is witnessing a continuous growth due to the availability of animal medicines globally, increase in disposable incomes of pet owners and economic development that contribute to the growth of the animal medicine market.
Global Animal Health Products: The global animal antibacterial and antibiotics market is consists of animal health products which enhance the quality of life of animals. This market has witnessed a drastic growth over the past years and is still continuing. The leading vendors in the global animal antibacterial and antibiotics market are Zoetis, Merck Animal Health, Merial, Elanco, and Bayer HealthCare. The advancements in veterinary therapeutics, animal preventive medicines, increase in disposable income has boosted the demand for better animal medicines and animal health products. The global animal antibacterial and antibiotics market consists of Tetracyclines, penicillins, sulfonamides, macrolides, aminoglycosides, and cephalosporins. This is the largest class of animal drugs administered to prevent bacterial translation, prevents animal protein synthesis, and promotes animal growth.
Future of Global Animal Medicine Market: The global animal medicine market is valued in billions and North America is the largest consumer of animal medicine in the world. The global animal medicine market is driven by a significant rise in the zoonotic and food-borne diseases in animals. This trend has led the veterinary companies to produce more advanced vaccines and pharmaceuticals. Majority of the companies have made efforts to control pathogen contamination risks and food-borne diseases, which contributed towards the animal medicine market growth. Globally many initiatives were proposed to promote veterinary products presumed to drive the overall animal medicine market over the coming years.
Key Topics Covered in the Report:
·         Animal Medicine Market Size and Growth
·         Global Animal care industry research report
·         Animal Medicine Market Research Report
·         Animal Medicine Trends and Developments
·         Animal Medicine Market Country Analysis
·         North America Animal Medicine Market Research Report
·         Europe Animal Medicine Market Research Report
·         Asia Animal Medicine Market Research Report
·         Global Animal Medicine Market Major Players 
·         Animal Medicine Market Future Outlook
·         Global Animal Medicine Market Product Pipeline
·         Animal  Care Market Research report
·         Animal Feed Industry Analysis

To know more, click on the link below:
Related Reports


Contact Us:                                                                                          
Ken Research
Ankur Gupta, Head Marketing & Communications
0124-4230204



Global Bladder Cancer Clinical Trials Market Outlook

GlobalData'sclinical trial report, Bladder Cancer Global Clinical Trials Review, H2, 2017" provides an overview of Bladder Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Bladder Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using GlobalData'sproprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

The report provides a snapshot of the global clinical trials landscape Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment The Report provides enrollment trends for the past five years Report provides latest news for the past three months

Key Topics Covered in the Report:
Global Bladder Cancer Clinical Trials Market Outlook
Global Bladder Cancer Clinical Trials Market Size
Global Bladder Cancer Clinical Trials Market Trends
Global Bladder Cancer Clinical Trials Market Share
Global Bladder Cancer Clinical Trials Market Revenue
Global Bladder Cancer Clinical Trials Market Analysis
Global Bladder Cancer Clinical Trials Market Growth
Global Bladder Cancer Clinical Trials Market Volume
Global Bladder Cancer Clinical Trials Market
Global Bladder Cancer Clinical Trials Market Forecast

To know more, click on the link below:

Contact:        
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-124-4230204

Growth Hormone Deficiency Global Clinical Trials Review H2 2017: Ken Research

GlobalData'sclinical trial report, Growth Hormone Deficiency Global Clinical Trials Review, H2, 2017" provides an overview of Growth Hormone Deficiency clinical trials scenario. This report provides top line data relating to the clinical trials on Growth Hormone Deficiency. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using GlobalData'sproprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

The report provides a snapshot of the global clinical trials landscape Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment The Report provides enrollment trends for the past five years Report provides latest news for the past three months

Key Topics Covered in the Report:
Growth Hormone Deficiency Global Clinical Trials
Global Growth Hormone Deficiency Clinical Trials Market
Global Growth Hormone Deficiency Clinical Trials Market Trends
Global Growth Hormone Deficiency Clinical Trials Market Size
Global Growth Hormone Deficiency Clinical Trials Market Outlook
Global Growth Hormone Deficiency Clinical Trials Market Forecast
Global Growth Hormone Deficiency Clinical Trials Market Volume
Global Growth Hormone Deficiency Clinical Trials Market Value
Global Growth Hormone Deficiency Clinical Trials Market Share
Global Growth Hormone Deficiency Clinical Trials Market Revenue

To know more, click on the link below:

Contact:        
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-124-4230204

Mineral Deficiency Global Clinical Trials Report : Ken Research


GlobalData's clinical trial report, "Mineral Deficiency Global Clinical Trials Review, H2, 2017" provides an overview of Mineral Deficiency clinical trials scenario. This report provides top line data relating to the clinical trials on Mineral Deficiency. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using GlobalData's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. The report provides a snapshot of the global clinical trials landscape. Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status. The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company.The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment. The Report provides enrollment trends for the past five years. Report provides latest news for the past 
three months.

Reasons to Buy:-

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Key Topics covered in the report:-

Mineral Deficiency Global Clinical Review

Mineral Deficiency Global Clinical Market Research Report

Mineral Deficiency Global Clinical Market Major Players

Mineral Deficiency Global Clinical Market Size

Mineral Deficiency Global Clinical Market share

Mineral Deficiency Global Clinical Market trends

Mineral Deficiency Global Clinical Market growth

Mineral Deficiency Global Clinical Market Revenue

To know more about the publication, click on the link below:


Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249


Friday, March 9, 2018

Global Nocturia Therapeutics Clinical Trials Market Research Report to 2017: Ken Research

GlobalData'sclinical trial report, Nocturia Global Clinical Trials Review, H2, 2017" provides an overview of Nocturia clinical trials scenario. This report provides top line data relating to the clinical trials on Nocturia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using GlobalData'sproprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

The report provides a snapshot of the global clinical trials landscape Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment The Report provides enrollment trends for the past five years Report provides latest news for the past three months

Key Topics Covered in the Report:
Global Nocturia Clinical Trials Market Research Report
Global Nocturia Clinical Trials Market
Global Nocturia Clinical Trials Market Trends
Global Nocturia Clinical Trials Industry Research
Global Nocturia Clinical Trials Market SWOT Analysis
Global Nocturia Clinical Trials Market Size
Global Nocturia Clinical Trials Market Growth
Global Nocturia Clinical Trials Market Outlook
Global Nocturia Clinical Trials Market Revenue
Global Nocturia Clinical Trials Market Share

To know more, click on the link below:

Contact:        
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-124-4230204

Asia-Pacific emerged as the largest market for haircare worldwide by Recording value share of 40.3% in the year 2016: Ken Research


Regional Overview: According to the research report, “Opportunities in the Asia-Pacific Haircare Sector: Analysis of Opportunities Offered by High Growth Economies”, the global haircare sector was valued at USD 69,439.7 million in year 2017 and is estimated to reach USD 82,040.3 million by the year 2022, growing at a CAGR of 3.4% during the period 2017–2022. The Asia-Pacific haircare sector accounts for 35.2% share of the global market, which was valued at USD 24,470.1 million in the year 2017. The haircare sector is forecast to reach USD 32,824.6 million by the year 2022, growing at a CAGR of 6.1% during the period 2017–2022.

Sector Overview: Of the seven categories, shampoo holds the largest share that accounts for 50.4% of the total value sales followed by conditioner that accounts for an aggregate value share of 27.5% in the year 2017. A projected value CAGR of 7% will be witnessed during the period 2017–2022, however, the shampoo category is set to record the fastest growth amid all the haircare categories in the Asia-Pacific Haircare Sector.

High Potential Countries: The haircare sector in Asia-Pacific is geographically spread across China, Malaysia, Philippines, and India. These countries are identified as the high potential counties for the haircare products in the Asia-Pacific region. China will witness a highest volume CAGR of 9.1%, followed by India that will witness a volume CAGR of 7.4% during the period 2017–2022.

Brand Analysis: Hypermarkets & supermarkets was the leading distribution channels for haircare products in the Asia-Pacific region, accounting for 31.1% of total value sales in 2017, while convenience stores, the second-largest channel, registered a 27.3% value share.

Distribution Channels: The leading distributors for haircare products in the Asia-Pacific region are hypermarkets, supermarkets and convenience stores. Hypermarkets & supermarkets are the leading distribution channels that registered 31.1% of total value sales, while convenience stores registered 27.3% value sales in the year 2017 for haircare products in the Asia-Pacific region.

Packaging Formats: The most common package material used in the Asia-Pacific haircare sector is flexible packaging which registered a volume share of 61.4%, followed by rigid plastics which registered a volume share of 36.8% in the year 2017. The usage of flexible packaging has witness a faster growth during the period 2012–2022, and is followed by rigid plastics.

Key Topics Covered in the Report:-
                    ·         Asia Haircare Market Research Report
·         India Haircare Market Research
·         China Hair Care Market Research Report
·         Philippines Haircare Industry Revenue
·         Haircare Industry Competition
·         Asia Haircare Major Players Market Share
·         Hair care Market Asia Distribution Channels
·         Asia Cosmetics Industry Research Report
·         Asia Haircare Market Forecast
·         Asia Haircare Market Future Outlook
·         Asia Haircare Market Growth Analysis
·         China Hair Care Market Forecast

To know more, click on the link below:


Related Reports:


Contact Us:                                                                                          
Ken Research
Ankur Gupta, Head Marketing & Communications
0124-4230204